| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 1063 |
| 1 | METHOTREXATE | 1026 |
| 2 | LEFLUNOMIDE | 1023 |
| 3 | ADALIMUMAB | 1021 |
| 4 | ETANERCEPT | 1003 |
| 5 | RITUXIMAB | 995 |
| 6 | ABATACEPT | 989 |
| 7 | PREDNISONE | 960 |
| 8 | INFLIXIMAB | 959 |
| 9 | SULFASALAZINE | 935 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HYDROCHLORIDE | 23 | 0.1179 |
| 1 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 42 | 0.0638 |
| 2 | CAFFEINE CITRATE | 139 | 0.0596 |
| 3 | GOLIMUMAB | 694 | 0.0551 |
| 4 | HYDROCORTISONE BUTYRATE | 81 | 0.0410 |
| 5 | TRICLOSAN | 21 | 0.0364 |
| 6 | PSEUDOEPHEDRINE HCL | 372 | 0.0340 |
| 7 | CORTISONE ACETATE | 402 | 0.0322 |
| 8 | TOFACITINIB CITRATE | 425 | 0.0317 |
| 9 | GOLD | 182 | 0.0313 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 1178 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 1108 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 1037 |
| 3 | Antirheumatic Agent [EPC] | 1025 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1010 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 1005 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 989 |
| 7 | Aminosalicylate [EPC] | 971 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 945 |
| 9 | Vitamin C [EPC] | 695 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 92 | 0.0496 |
| 1 | Interleukin-5 Antagonist [EPC] | 30 | 0.0436 |
| 2 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 146 | 0.0167 |
| 3 | Provitamin D2 Compound [EPC] | 445 | 0.0150 |
| 4 | Interleukin-17A Antagonist [EPC] | 474 | 0.0127 |
| 5 | Antirheumatic Agent [EPC] | 1025 | 0.0097 |
| 6 | Aminosalicylate [EPC] | 971 | 0.0096 |
| 7 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 989 | 0.0071 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 945 | 0.0068 |